| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |